Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study

Letter/Communication

Open access

Brian K. Link, Bann‐mo Day, Xiaolei Zhou, Andrew D. Zelenetz, Keith L. Dawson, James R. Cerhan, Christopher R. Flowers and Jonathan W. Friedberg

British journal of haematology, Vol.184(4), pp.660-663

02/2019

DOI: 10.1111/bjh.15149

PMID: 29611177

Files and links (1)

url

https://doi.org/10.1111/bjh.15149View

Published (Version of record) Open Access

B‐cell neoplasms

clinical results in lymphoma

immunotherapeutic approaches

rituximab

treatment patterns

Title: Subtitle: Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
Creators: Brian K. Link - University of Iowa
Bann‐mo Day - Genentech
Xiaolei Zhou - RTI Health Solutions
Andrew D. Zelenetz - Memorial Sloan Kettering Cancer Center
Keith L. Dawson - Genentech
James R. Cerhan - Mayo Clinic
Christopher R. Flowers - Emory University
Jonathan W. Friedberg - University of Rochester
Resource Type: Letter/Communication
Publication Details: British journal of haematology, Vol.184(4), pp.660-663
DOI: 10.1111/bjh.15149
PMID: 29611177
NLM abbreviation: Br J Haematol
ISSN: 0007-1048
eISSN: 1365-2141
Number of pages: 4
Grant note: Genentech Inc
Language: English
Date published: 02/2019
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
Record Identifier: 9984359574602771

18 Record Views